| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000242516.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.035362465 |
Sensitive |
| ENSG00000242516.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000533051 |
Sensitive |
| ENSG00000242516.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.004731433 |
Sensitive |
